HOME >> MEDICINE >> NEWS
Estrogen has antitumor activity in hormone therapy-resistant breast tumors

A pair of studies in the November 5 issue of the Journal of the National Cancer Institute suggest that low levels of estrogen--the same hormone that promotes breast cancer in its early stages--can shrink breast tumors that have developed resistance to the drugs tamoxifen and raloxifene.

Tamoxifen is a selective estrogen receptor modulator (SERM) used to treat estrogen receptor-positive breast cancers and prevent recurrence of the disease. However, tamoxifen often loses effectiveness over time and can subsequently stimulate breast cancer growth. New endocrine therapies, such as aromatase inhibitors and the antiestrogen fulvestrant, are being are used to augment the effects of tamoxifen, although some studies are suggesting that low levels of estrogen may also inhibit the growth of tamoxifen-stimulated breast tumors.

Clodia Osipo, Ph.D., and V. Craig Jordan, Ph.D., D.Sc., of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago, and their colleagues examined the effect of tamoxifen, the estrogen estradiol, and fulvestrant, both alone and in various combinations, in a mouse model of tamoxifen-stimulated human breast cancer.

The researchers found that low levels of estradiol caused tamoxifen-resistant breast tumors to regress, apparently by increasing apoptosis (cell suicide) through decreased expression of Her2/neu and NF-κB, two factors that inhibit apoptosis, and increased expression of the death receptor protein Fas, which regulates apoptosis.

Combined treatment with fulvestrant plus estradiol unexpectedly promoted the growth of tamoxifen-stimulated breast tumors, suggesting that the use of fulvestrant in patients with sufficient levels of circulating estrogen may actually stimulate tumor growth.

In the second study, Hong Liu, M.D., Ph.D., of the Robert H. Lurie Comprehensive Cancer Center, Jordan, and their colleagues examined whether low doses of estradiol would also have an
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Dec-2000


Page: 1 2

Related medicine news :

1. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
2. Estrogen or stimulating environment boost memory
3. Estrogenlike drugs may eventually help postmenopausal women with weight gain
4. Estrogen offers no overall benefit for disease prevention in postmenopausal women with hysterectomy
5. Estrogen makes the brain more vulnerable to stress
6. Estrogen replacement increases risk factors for arrhythmia and sudden death
7. Estrogen may lower womens risk of heart disease by working as damper on inflammation
8. Estrogen may dictate what problem-solving strategy brain uses
9. Testosterone may reduce risk of stroke in men; Estrogen levels not related to stroke
10. Estrogens role in preventing female cardiac disease
11. Estrogen shows potential as stroke treatment, UF animal studies show

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... What unique insights can three former Surgeons General ... wellness in the nation? That question will be answered at ICAA 2019: Shaping the ... Expo. The event will take place October 10-12, 2019, at the Gaylord Palms Resort ...
(Date:10/8/2019)... ... October 08, 2019 , ... Cognosante has been awarded a ... Affairs Community Care Referrals and Authorizations program. The new task order will allow ... Manager (HSRM), an enterprise-wide system used by community care staff to generate referrals ...
(Date:10/8/2019)... ... October 08, 2019 , ... Over the past three decades, Buffalo Wings ... the sports restaurant category by providing a higher-quality product and experience than the competition. ... well as a "RAISE A MUG FOR THE CAUSE" campaign in support of Breast ...
(Date:10/8/2019)... ... October 08, 2019 , ... The ... a Digital Health Awards 1st Round (Top Ten) Finalist in its Best ... to select companies that promote faster, better, more cost-effective healthcare by improving outcomes ...
(Date:10/8/2019)... ... October 08, 2019 , ... Fewer than 50 ... year, are reproducible. Rigor in bioanalytical method validation is emerging in the form ... than half of the time) and senior scientists add the management of an ...
Breaking Medicine News(10 mins):
(Date:10/10/2019)... NATOMAS, Calif. (PRWEB) , ... October 10, 2019 , ... ... of Dr. Glenn Misono in Natomas, California and opening of a new A+ location ... with seven convenient locations across the Sacramento area. The group’s 14 general dentists and ...
(Date:10/9/2019)... ... October 09, 2019 , ... Drs. Steven White, Brad Haines ... with obstructive sleep apnea in Davidson, NC. If left untreated, sleep apnea ... under the care of a skilled dentist, those who suffer from snoring at night ...
(Date:10/8/2019)... ... ... Dr. Ryan McNally, ND, MS, PA and Dr. Shashita Inamdar, MD, PhD, DABPN ... presentation titled Advances in Integrative Neuropsychiatry and Functional Mental Health, will evaluate the pros ... health, and reduce the debilitating symptoms of a range of neuropsychiatric disorders. , ...
Breaking Medicine Technology:
Cached News: